(XPEV) Xpeng - Ratings and Ratios
Electric Vehicles, Smart Cars, SUVs, Sedans, Hatchbacks
XPEV EPS (Earnings per Share)
XPEV Revenue
Description: XPEV Xpeng
XPeng Inc. is a Chinese electric vehicle (EV) manufacturer that designs, develops, and markets smart EVs, including models such as P7, G9, G6, and MONA M03. The company also provides various services, including supercharging, maintenance, and insurance technology support.
From a business perspective, XPeng has been expanding its product lineup and investing in its manufacturing capabilities. The companys revenue growth has been driven by increasing deliveries of its EVs, with a reported delivery count of over 140,000 units in 2022. XPengs gross margin has also been improving, driven by cost reductions and economies of scale.
Key performance indicators (KPIs) to watch for XPeng include delivery numbers, revenue growth, and gross margin expansion. The companys ability to manage its cash burn and achieve profitability will also be crucial in determining its long-term success. Additionally, XPengs research and development (R&D) expenses as a percentage of revenue, currently around 10-15%, indicate its commitment to innovation and staying competitive in the rapidly evolving EV market.
From a financial perspective, XPengs market capitalization is around $16.6 billion, with a negative P/E ratio due to its current losses. The companys return on equity (RoE) is also negative, at -15.89%. Investors should monitor XPengs progress towards achieving profitability and its ability to generate returns on equity.
XPEV Stock Overview
| Market Cap in USD | 19,630m |
| Sub-Industry | Automobile Manufacturers |
| IPO / Inception | 2020-08-27 |
XPEV Stock Ratings
| Growth Rating | 34.7% |
| Fundamental | 39.4% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 101% |
| Analyst Rating | 4.21 of 5 |
XPEV Dividends
Currently no dividends paidXPEV Growth Ratios
| Growth Correlation 3m | 76.3% |
| Growth Correlation 12m | 76.1% |
| Growth Correlation 5y | -60.8% |
| CAGR 5y | 11.00% |
| CAGR/Max DD 3y | 0.15 |
| CAGR/Mean DD 3y | 0.29 |
| Sharpe Ratio 12m | 0.49 |
| Alpha | 118.37 |
| Beta | 0.655 |
| Volatility | 71.61% |
| Current Volume | 6616.1k |
| Average Volume 20d | 8502.1k |
| Stop Loss | 20.4 (-4.4%) |
| Signal | -0.72 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-4.28b TTM) > 0 and > 6% of Revenue (6% = 3.62b TTM) |
| FCFTA -0.05 (>2.0%) and ΔFCFTA -4.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.29% (prev 41.22%; Δ -29.93pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -2.01b > Net Income -4.28b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (951.2m) change vs 12m ago -49.62% (target <= -2.0% for YES) |
| Gross Margin 15.75% (prev 7.07%; Δ 8.68pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 72.02% (prev 48.32%; Δ 23.70pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -8.28 (EBITDA TTM -2.81b / Interest Expense TTM 537.3m) >= 6 (WARN >= 3) |
Altman Z'' -2.07
| (A) 0.07 = (Total Current Assets 54.77b - Total Current Liabilities 47.96b) / Total Assets 92.43b |
| (B) -0.46 = Retained Earnings (Balance) -42.74b / Total Assets 92.43b |
| (C) -0.05 = EBIT TTM -4.45b / Avg Total Assets 83.71b |
| (D) -0.65 = Book Value of Equity -40.58b / Total Liabilities 62.09b |
| Total Rating: -2.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 39.37
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield -3.38% = -1.69 |
| 3. FCF Margin -7.36% = -2.76 |
| 4. Debt/Equity 0.84 = 2.16 |
| 5. Debt/Ebitda -9.06 = -2.50 |
| 6. ROIC - WACC -16.65% = -12.50 |
| 7. RoE -13.77% = -2.29 |
| 8. Rev. Trend 83.40% = 6.26 |
| 9. EPS Trend 83.95% = 4.20 |
What is the price of XPEV shares?
Over the past week, the price has changed by +3.64%, over one month by +8.27%, over three months by +14.37% and over the past year by +139.13%.
Is Xpeng a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XPEV is around 20.66 USD . This means that XPEV is currently overvalued and has a potential downside of -3.14%.
Is XPEV a buy, sell or hold?
- Strong Buy: 14
- Buy: 7
- Hold: 6
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the XPEV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.4 | 23.6% |
| Analysts Target Price | 26.4 | 23.6% |
| ValueRay Target Price | 22.8 | 6.7% |
Last update: 2025-09-13 05:06
XPEV Fundamental Data Overview
CCE Cash And Equivalents = 33.87b CNY (Cash And Short Term Investments, last quarter)
P/E Forward = 50.7614
P/S = 0.3256
P/B = 4.4946
Beta = 2.504
Revenue TTM = 60.29b CNY
EBIT TTM = -4.45b CNY
EBITDA TTM = -2.81b CNY
Long Term Debt = 5.79b CNY (from longTermDebt, last quarter)
Short Term Debt = 19.67b CNY (from shortTermDebt, last quarter)
Debt = 25.46b CNY (Calculated: Short Term 19.67b + Long Term 5.79b)
Net Debt = 11.86b CNY (from netDebt column, last quarter)
Enterprise Value = 131.34b CNY (139.75b + Debt 25.46b - CCE 33.87b)
Interest Coverage Ratio = -8.28 (Ebit TTM -4.45b / Interest Expense TTM 537.3m)
FCF Yield = -3.38% (FCF TTM -4.44b / Enterprise Value 131.34b)
FCF Margin = -7.36% (FCF TTM -4.44b / Revenue TTM 60.29b)
Net Margin = -7.10% (Net Income TTM -4.28b / Revenue TTM 60.29b)
Gross Margin = 15.75% ((Revenue TTM 60.29b - Cost of Revenue TTM 50.80b) / Revenue TTM)
Tobins Q-Ratio = -3.24 (set to none) (Enterprise Value 131.34b / Book Value Of Equity -40.58b)
Interest Expense / Debt = 0.30% (Interest Expense 75.2m / Debt 25.46b)
Taxrate = 21.0% (US default)
NOPAT = -4.45b (EBIT -4.45b, no tax applied on loss)
Current Ratio = 1.14 (Total Current Assets 54.77b / Total Current Liabilities 47.96b)
Debt / Equity = 0.84 (Debt 25.46b / last Quarter total Stockholder Equity 30.34b)
Debt / EBITDA = -9.06 (Net Debt 11.86b / EBITDA -2.81b)
Debt / FCF = -5.73 (Debt 25.46b / FCF TTM -4.44b)
Total Stockholder Equity = 31.09b (last 4 quarters mean)
RoA = -4.63% (Net Income -4.28b, Total Assets 92.43b )
RoE = -13.77% (Net Income TTM -4.28b / Total Stockholder Equity 31.09b)
RoCE = -12.07% (Ebit -4.45b / (Equity 31.09b + L.T.Debt 5.79b))
RoIC = -9.48% (NOPAT -4.45b / Invested Capital 46.93b)
WACC = 7.17% (E(139.75b)/V(165.21b) * Re(8.43%)) + (D(25.46b)/V(165.21b) * Rd(0.30%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 54.55 | Cagr: 0.93%
Discount Rate = 8.43% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -4.44b)
EPS Correlation: 83.95 | EPS CAGR: 39.42% | SUE: 0.66 | # QB: False
Revenue Correlation: 83.40 | Revenue CAGR: 43.08%
Additional Sources for XPEV Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle